Ana S. Leal

Also affiliated with Indiana University – Purdue University Indianapolis

Biochemistry, Genetics and Molecular BiologyChemistry

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “The rexinoid V-125 reduces tumor growth in preclinical models of breast and lung cancer”.

The rexinoid V-125 reduces tumor growth in preclinical models of breast and lung cancer

Scientific Reports(2022)10.1038/s41598-021-04415-0

N/A

0DataRank · unranked

18 citations

Jessica A. Moerland, Ana S. Leal, Di Zhang, Sarah Carapellucci, Beth Lockwood +5 more

The Multi-Faceted Consequences of NRF2 Activation throughout Carcinogenesis

Molecules and Cells(2023)10.14348/molcells.2023.2191

N/A

0DataRank · unranked

38 citations

Jessica A. Moerland, Ana S. Leal, Kathleen A. Gallo, Karen T. Liby, Christopher J. Occhiuto

Retinoid X Receptor agonists as selective modulators of the immune system for the treatment of cancer

Pharmacology & Therapeutics(2023)10.1016/j.pharmthera.2023.108561

N/A

0DataRank · unranked

24 citations

Pei‐Yu Hung, A. Chowdhury, Karen T. Liby, Ana S. Leal

The BRD4 Inhibitor I-BET-762 Reduces HO-1 Expression in Macrophages and the Pancreas of Mice

International Journal of Molecular Sciences(2024)10.3390/ijms25189985

N/A

0DataRank · unranked

4 citations

Karen T. Liby, Ana S. Leal

Synthetic Oleanane Triterpenoids Reduce Tumor Growth and Promote an Anti-Tumor Immune Response Independent of Cancer KEAP1 Mutational Status

Antioxidants(2025)10.3390/antiox14121406

N/A

0DataRank · unranked

0 citations

Jessica A. Moerland, Karen T. Liby, Ana S. Leal, Christopher J. Occhiuto